- Home
- ZK vs LEGN Comparison
ZK vs LEGN Comparison
Compare ZK & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZK
- LEGN
- Stock Information
- Founded
- ZK 2017
- LEGN 2014
- Country
- ZK China
- LEGN United States
- Employees
- ZK N/A
- LEGN N/A
- Industry
- ZK
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- ZK
- LEGN Health Care
- Exchange
- ZK NYSE
- LEGN Nasdaq
- Market Cap
- ZK 6.5B
- LEGN 7.0B
- IPO Year
- ZK 2024
- LEGN 2020
- Fundamental
- Price
- ZK $25.18
- LEGN $38.09
- Analyst Decision
- ZK Strong Buy
- LEGN Strong Buy
- Analyst Count
- ZK 3
- LEGN 12
- Target Price
- ZK $30.80
- LEGN $79.50
- AVG Volume (30 Days)
- ZK 427.0K
- LEGN 1.4M
- Earning Date
- ZK 02-14-2025
- LEGN 03-10-2025
- Dividend Yield
- ZK N/A
- LEGN N/A
- EPS Growth
- ZK N/A
- LEGN N/A
- EPS
- ZK N/A
- LEGN N/A
- Revenue
- ZK $9,907,011,177.00
- LEGN $520,183,000.00
- Revenue This Year
- ZK N/A
- LEGN $121.04
- Revenue Next Year
- ZK $38.30
- LEGN $67.39
- P/E Ratio
- ZK N/A
- LEGN N/A
- Revenue Growth
- ZK 42.56
- LEGN 122.96
- 52 Week Low
- ZK $13.00
- LEGN $30.17
- 52 Week High
- ZK $32.76
- LEGN $70.13
- Technical
- Relative Strength Index (RSI)
- ZK N/A
- LEGN 58.97
- Support Level
- ZK N/A
- LEGN $36.59
- Resistance Level
- ZK N/A
- LEGN $37.91
- Average True Range (ATR)
- ZK 0.00
- LEGN 1.80
- MACD
- ZK 0.00
- LEGN 0.52
- Stochastic Oscillator
- ZK 0.00
- LEGN 79.68
About ZK ZEEKR INTELLIGENT TECHNOLOGY HLDG L SPON ADS EA REP 10 ORD SHS
ZEEKR Intelligent Technology Holding Ltd is a fast-growing BEV technology company. By developing and offering next-generation premium BEVs and technology-driven solutions, It aspires to lead the automobile industry's electrification, intelligentization and innovation. Since its inception, It has focused on innovation in BEV architecture, hardware, software, and application of new technologies. It is principally engaged in the commercialization and sales of electric vehicles and batteries, and the provision of automotive-related research and development services.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.